Recursion Unveils LOWE Drug Discovery Software at the J.P. Morgan Healthcare Conference

January 8, 2024

https://www.globenewswire.com/news-release/2024/01/08/2805630/0/en/Recursion-Unveils-LOWE-Drug-Discovery-Software-at-the-J-P-Morgan-Healthcare-Conference.html

SAN FRANCISCO, Jan. 08, 2024 (GLOBE NEWSWIRE) — Recursion (NASDAQ:RXRX), a leading clinical stage TechBio company decoding biology to industrialize drug discovery, today presented a demonstration of LOWE (Large Language Model-Orchestrated Workflow Engine), its new software designed to perform complex drug discovery tasks using a natural language interface. LOWE is powered by Recursion’s proprietary biological and chemical data and can orchestrate experiments using Recursion’s automated wet laboratories, unleashing the power of the Recursion Operating System in an easy-to-use tool.

Read more at globenewswire.com

Related news for (RXRX)

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.